Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly versus every-3-weeks paclitaxel in advanced or metastatic breast cancer
ISRCTN52817670Phase 3Completed
- Sponsor
- Anglo Celtic Cooperative Oncology Group
- Start
- Sep 2002
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of paclitaxel in breast cancer (2 arms), sponsored by Anglo Celtic Cooperative Oncology Group. Primary endpoints: Time to disease progression and Pharmacogenetic association. Started Sep 2002; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN52817670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN52817670.